Premium
Fusarium. A newly recognized fungal pathogen in immunosuppressed patients
Author(s) -
Anaissie Elias,
Kantarjian Hagop,
Jones Paula,
Barlogie Barthel,
Luna Mario,
Lopez GabrielBerestein,
Bodey Gerald P.
Publication year - 1986
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19860601)57:11<2141::aid-cncr2820571110>3.0.co;2-n
Subject(s) - medicine , fusarium , amphotericin b , pathogen , fungal pathogen , voriconazole , antifungal , immunology , dermatology , biology , botany
Two cases of disseminated fungal infection due to Fusarium species, that occurred during a 4‐month period, are reported. Both patients had a myeloproliferative disorder for which they had received intensive cytotoxic and immunosuppressive therapy, and both died despite treatment with amphotericin B. This report and review of the recent literature suggest that Fusarium is emerging as a newly recognized fungal pathogen in immunosuppressed patients.